Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat frontoparietal cortex

Brain Res. 1987 Sep 22;421(1-2):377-81. doi: 10.1016/0006-8993(87)91312-6.

Abstract

Sertraline, a potent and selective inhibitor of serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]dihydroalprenolol ([3H]DHA) was reduced in cortex layers IV-VI. Results of a saturation experiment indicated that the reduction in cortex layer IV was due to a change in number but not affinity of beta-adrenergic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Naphthylamine / administration & dosage*
  • 1-Naphthylamine / analogs & derivatives
  • Animals
  • Autoradiography
  • Dihydroalprenolol / metabolism
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism*
  • In Vitro Techniques
  • Male
  • Naphthalenes / administration & dosage*
  • Parietal Lobe / drug effects
  • Parietal Lobe / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / metabolism*
  • Serotonin / metabolism*
  • Sertraline

Substances

  • Naphthalenes
  • Receptors, Adrenergic, beta
  • Serotonin
  • Dihydroalprenolol
  • 1-Naphthylamine
  • Sertraline